Request Deal Involvement

AstraZeneca completed the acquisition of Gracell Biotechnologies for $1.2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Gibson Dunn & Crutcher

legal advisors to financial advisors

Gibson Dunn & Crutcher

Centerview Partners

financial advisors

Centerview Partners

Cooley

legal advisors

Cooley

AllBright Law Office

legal advisors

AllBright Law Office

Harney Westwood & Riegels

legal advisors

Harney Westwood & Riegels

Westwicke

pr advisors

Westwicke

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

RuiMin

legal advisors

RuiMin

Maples Group

legal advisors

Maples Group

or

Principals

GRACELL BIOTECHNOLOGIES INC

target

GRACELL BIOTECHNOLOGIES INC

ASTRAZENECA PLC

bidder

ASTRAZENECA PLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - AstraZeneca completed the acquisition of Gracell Biotechnologies for $1.2bn.